Moleculin Biotech, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2019 BioSpace
HOUSTON, Aug. 16, 2019 /PRNewswire/ — Moleculin Biotech Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company …